Found 14 matching trials
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA
PHASE3The primary objective of this study is to assess the efficacy of fostamatin...
Location
Banner MD Anderson Cancer Center
Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus
PHASE2Approximately 225 patients meeting study entry requirements will be enrolle...
Location
Multiple Locations
Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3)
PHASE2The purpose of this study is to determine whether the Spleen Tyrosine Kinas...
Location
Arthritis & Rheumatic Disease Specialties
Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis
PHASE2The purpose of this study is to determine whether the Spleen Tyrosine Kinas...
Location
Divison of Rheumatology Allergy and Immunology
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
PHASE3The primary objective of this study is:
• To evaluate the long-term safety...
Status
Enrolling By Invitation
Location
University of Southern California - Janice and Robert Hall Clinical Trials Biospecimen Laboratory
Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
PHASE2The purpose of this study is to determine whether Fostamatinib Disodium is ...
A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
PHASE3The purpose of this study is to determine whether fostamatinib is safe and ...
Location
Arizona Oncology Associates
Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies
PHASE2The purpose of this new research study is to gain additional information ab...
Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP
N/AC-935788-055 is an open-label, multi-center, expanded access (EAP) study....
Status
No Longer Available
Location
Multiple Locations
Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
PHASE3The primary objective of this study was to assess the long term safety of f...
Location
Arizona Oncology Associates